MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SNDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Syndax Pharmaceuticals (SNDX) Ownership - Who owns Syndax Pharmaceuticals?

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
730 Third Avenue
Phone
+1 781 419-1400
Employees
277
Web
https://www.syndax.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.71B
P/E Ratio
N/A
Total Cash
361.24M
Projected Growth
N/A
Total Debt
345.36M
Revenue
217.17M
Risk (Beta)
0.54
Dividend Yield
N/A
Total Cash/Share
4.08
Total Debt/Equity
N/A
Revenue/Share
2.49 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SNDX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SNDX
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals for novel cancer therapies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
730 Third Avenue
Phone
+1 781 419-1400
Employees
277
Web
https://www.syndax.com